PL3318278T3 - Kompozycja farmaceutyczna obejmująca kolagen i hialuronian sodu - Google Patents

Kompozycja farmaceutyczna obejmująca kolagen i hialuronian sodu

Info

Publication number: PL3318278T3
Authority: PL; Poland
Prior art keywords: collagen; pharmaceutical compositions; sodium hyaluronate; hyaluronate; sodium
Prior art date: 2013-05-30

Application number

PL17202082T

Other languages

English (en)

Inventor

Giovanni Gennari

Susi Panfilo

Juan Francisco Scalesciani

Original Assignee

Fidia Farmaceutici S.P.A.

Euroresearch S.R.L.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2013-05-30

Filing date

2014-05-29

Publication date

2020-05-18

2014-05-29 Application filed by Fidia Farmaceutici S.P.A., Euroresearch S.R.L. filed Critical Fidia Farmaceutici S.P.A.

2020-05-18 Publication of PL3318278T3 publication Critical patent/PL3318278T3/pl

Links

102000008186 Collagen Human genes 0.000 title 1
108010035532 Collagen Proteins 0.000 title 1
229920002385 Sodium hyaluronate Polymers 0.000 title 1
229920001436 collagen Polymers 0.000 title 1
239000008194 pharmaceutical composition Substances 0.000 title 1
229940010747 sodium hyaluronate Drugs 0.000 title 1
YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/727—Heparin; Heparan
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/728—Hyaluronic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/38—Silver; Compounds thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
- A61K8/65—Collagen; Gelatin; Keratin; Derivatives or degradation products thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7007—Drug-containing films, membranes or sheets
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7015—Drug-containing film-forming compositions, e.g. spray-on
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/18—Antioxidants, e.g. antiradicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Dermatology (AREA)
Inorganic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Birds (AREA)
Diabetes (AREA)
Zoology (AREA)
Biomedical Technology (AREA)
Immunology (AREA)
Gastroenterology & Hepatology (AREA)
Gerontology & Geriatric Medicine (AREA)
Emergency Medicine (AREA)
Heart & Thoracic Surgery (AREA)
Obesity (AREA)
Cardiology (AREA)
Endocrinology (AREA)
Hematology (AREA)
Vascular Medicine (AREA)
Biochemistry (AREA)
Medicinal Preparation (AREA)
Materials For Medical Uses (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Cosmetics (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

PL17202082T 2013-05-30 2014-05-29 Kompozycja farmaceutyczna obejmująca kolagen i hialuronian sodu PL3318278T3 (pl)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
IT000883A ITMI20130883A1 (it)	2013-05-30	2013-05-30	Composizioni farmaceutiche comprendenti collagene e sodio ialuronato
EP14736979.7A EP3003379B1 (en)	2013-05-30	2014-05-29	Pharmaceutical compositions comprising collagen and sodium hyaluronate
PCT/IB2014/061816 WO2014191955A1 (en)	2013-05-30	2014-05-29	Pharmaceutical compositions comprising collagen and sodium hyaluronate
EP17202082.8A EP3318278B1 (en)	2013-05-30	2014-05-29	Pharmaceutical compositions comprising collagen and sodium hyaluronate

Publications (1)

Publication Number	Publication Date
PL3318278T3 true PL3318278T3 (pl)	2020-05-18

Family

ID=48748385

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
PL14736979T PL3003379T3 (pl)	2013-05-30	2014-05-29	Kompozycje farmaceutyczne obejmujące kolagen i hialuronian sodu
PL17202082T PL3318278T3 (pl)	2013-05-30	2014-05-29	Kompozycja farmaceutyczna obejmująca kolagen i hialuronian sodu

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
PL14736979T PL3003379T3 (pl)	2013-05-30	2014-05-29	Kompozycje farmaceutyczne obejmujące kolagen i hialuronian sodu

Country Status (13)

Country	Link
US (1)	US11241484B2 (pl)
EP (2)	EP3003379B1 (pl)
CN (2)	CN105407924B (pl)
EA (1)	EA034053B1 (pl)
ES (2)	ES2772718T3 (pl)
IT (1)	ITMI20130883A1 (pl)
LT (1)	LT3003379T (pl)
PL (2)	PL3003379T3 (pl)
SA (1)	SA515370220B1 (pl)
SI (1)	SI3003379T1 (pl)
SM (2)	SMT202000097T1 (pl)
TN (1)	TN2015000520A1 (pl)
WO (1)	WO2014191955A1 (pl)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2837626T3 (es)	2013-07-10	2021-07-01	Matrix Biology Inst	Composiciones de hialuronano con alta elasticidad y usos de las mismas
RU2020123728A (ru)	2015-09-24	2021-01-18	Матрикс Байолэджи Инститьют	Композиции гиалуроновой кислоты с высокоэластичными свойствами и способы их применения
ITUB20155223A1 (it) *	2015-10-22	2017-04-22	Icf Srl	Composizione spruzzabile secca e suo uso topico esterno in applicazioni veterinarie
ES2930285T3 (es) *	2017-02-03	2022-12-09	Biocellix Spa	Membrana o matriz de colágeno con propiedades antimicrobianas
CN109200338A (zh) *	2018-08-15	2019-01-15	白晋	一种具有玻尿酸的自体胶原蛋白凝胶的制备方法
US12246126B2 (en)	2019-02-28	2025-03-11	Cook Biotech Incorporated	Powder spray dispenser for comminuted ECM
KR102463375B1 (ko) *	2020-02-07	2022-11-07	한국과학기술연구원	콜라겐을 포함하는 마이크로 젤 조성물 및 제조 방법
CN111420023B (zh) *	2020-04-30	2024-03-15	广州市红十字会医院（暨南大学医学院附属广州红十字会医院）	含i型胶原和透明质酸的复合物及制备和用途
CN114699335B (zh) *	2022-04-25	2023-11-03	广州创尔生物技术股份有限公司	一种稳定的胶原蛋白-透明质酸互溶体系及其制备方法
CN116115515A (zh) *	2022-05-18	2023-05-16	广州创尔生物技术股份有限公司	一种稳定的ⅰ型胶原-离子型基质复合体系及其制备方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
LU85582A1 (fr)	1983-10-11	1985-06-04	Fidia Spa	Fractions d'acide hyaluronique ayant une activite pharmaceutique,procedes pour leur preparation et compositions pharmaceutiques les contenant
US4813942A (en) *	1987-03-17	1989-03-21	Bioderm, Inc.	Three step wound treatment method and dressing therefor
EP0907721A1 (en)	1996-05-28	1999-04-14	Brown University Research Foundation	Hyaluronan based biodegradable scaffolds for tissue repair
US20020025921A1 (en) *	1999-07-26	2002-02-28	Petito George D.	Composition and method for growing, protecting, and healing tissues and cells
DE19855890A1 (de)	1998-12-03	2000-06-08	Nerlich Michael	Poröse Kompositmatrix, deren Herstellung und Verwendung
JP2001226286A (ja) *	2000-02-16	2001-08-21	Rainbow:Kk	肌細胞活性物質
EP1259269B1 (en) *	2000-03-03	2008-06-18	Syntacoll AG	Agent for the treatment of wounds
US7098315B2 (en) *	2001-01-25	2006-08-29	Nycomed Pharma As	Method of preparing a collagen sponge, a device for extracting a part of a collagen foam, and an elongated collagen sponge
US7052713B2 (en) *	2001-02-13	2006-05-30	Nycomed Pharma As	Carrier with solid fibrinogen and solid thrombin
CN101791425B (zh) *	2010-03-30	2013-04-10	赵雪林	用于制备医用创伤敷料的抗菌促愈凝胶材料及其制备方法
US8790699B2 (en) *	2010-04-23	2014-07-29	Warsaw Orthpedic, Inc.	Foam-formed collagen strand
IT1402385B1 (it)	2010-09-09	2013-09-04	Fidia Farmaceutici	Processo per la produzione di acido ialuronico in escherichia coli o bacillus subtilis
IT1402384B1 (it)	2010-09-09	2013-09-04	Fidia Farmaceutici	Processo per la produzione di acido ialuronico in escherichia coli o bacillus megaterium
IT1402786B1 (it) *	2010-11-19	2013-09-18	Fidia Farmaceutici	Composizioni farmaceutiche ad attivita' antibatterica e cicatrizzante
CN102552968A (zh) *	2012-02-13	2012-07-11	江苏天麟生物医药科技有限公司	一种透明质酸胶原复合型烧伤生物膜的制备方法
CN102961396A (zh) *	2012-12-17	2013-03-13	程玉李	透明质酸金属盐在制备治疗皮肤病药物中的应用、其药物组合物及其制备方法

2013
- 2013-05-30 IT IT000883A patent/ITMI20130883A1/it unknown
2014
- 2014-05-28 SM SM20200097T patent/SMT202000097T1/it unknown
- 2014-05-29 CN CN201480030531.3A patent/CN105407924B/zh active Active
- 2014-05-29 WO PCT/IB2014/061816 patent/WO2014191955A1/en not_active Ceased
- 2014-05-29 SM SM20180599T patent/SMT201800599T1/it unknown
- 2014-05-29 TN TN2015000520A patent/TN2015000520A1/en unknown
- 2014-05-29 PL PL14736979T patent/PL3003379T3/pl unknown
- 2014-05-29 SI SI201430979T patent/SI3003379T1/sl unknown
- 2014-05-29 PL PL17202082T patent/PL3318278T3/pl unknown
- 2014-05-29 LT LTEP14736979.7T patent/LT3003379T/lt unknown
- 2014-05-29 EP EP14736979.7A patent/EP3003379B1/en active Active
- 2014-05-29 CN CN201910681497.0A patent/CN110404055A/zh active Pending
- 2014-05-29 EP EP17202082.8A patent/EP3318278B1/en active Active
- 2014-05-29 US US14/894,266 patent/US11241484B2/en active Active
- 2014-05-29 ES ES17202082T patent/ES2772718T3/es active Active
- 2014-05-29 EA EA201592073A patent/EA034053B1/ru not_active IP Right Cessation
- 2014-05-29 ES ES14736979T patent/ES2696282T3/es active Active
2015
- 2015-11-30 SA SA515370220A patent/SA515370220B1/ar unknown

Also Published As

Publication number	Publication date
TN2015000520A1 (en)	2017-04-06
US20160114003A1 (en)	2016-04-28
CN110404055A (zh)	2019-11-05
EA034053B1 (ru)	2019-12-23
US11241484B2 (en)	2022-02-08
PL3003379T3 (pl)	2019-02-28
SMT202000097T1 (it)	2020-03-13
EP3318278B1 (en)	2019-11-20
ES2696282T3 (es)	2019-01-14
ITMI20130883A1 (it)	2014-12-01
WO2014191955A1 (en)	2014-12-04
ES2772718T3 (es)	2020-07-08
EP3003379B1 (en)	2018-08-22
SMT201800599T1 (it)	2019-01-11
SI3003379T1 (sl)	2018-12-31
CN105407924A (zh)	2016-03-16
EP3003379A1 (en)	2016-04-13
EP3318278A1 (en)	2018-05-09
HK1222572A1 (zh)	2017-07-07
SA515370220B1 (ar)	2019-07-30
LT3003379T (lt)	2018-12-10
EA201592073A1 (ru)	2016-05-31
CN105407924B (zh)	2019-08-23

Publication	Publication Date	Title
IL288961A (en)	2022-02-01	Pharmaceutical preparations
IL240290A0 (en)	2015-09-24	History of pyridazinone-amide and pharmaceutical preparations containing them
IL241512B (en)	2020-08-31	Pharmaceutical preparations containing glycosidase inhibitors and their preparation
PL3003379T3 (pl)	2019-02-28	Kompozycje farmaceutyczne obejmujące kolagen i hialuronian sodu
IL236024A (en)	2016-09-29	The history of benzimidazole-proline and its pharmaceutical preparations
GB201301895D0 (en)	2013-03-20	Pharmaceutical compositions
ZA201505026B (en)	2016-07-27	Artificial tears comprising sodium hyaluronate and carboxymethylcellulose
ZA201408333B (en)	2015-12-23	Pharmaceutical compositions
ZA201602770B (en)	2017-04-26	Tyrosine derivatives and compositions comprising them
IL243435A0 (en)	2016-03-31	Pharmaceutical preparations of pancreatin with high potency
TWI562776B (en)	2016-12-21	Pharmaceutical composition and uses thereof
EP3052130A4 (en)	2017-05-31	Pharmaceutical composition comprising capecitabine and cyclophosphamide
AP2015008890A0 (en)	2015-11-30	Pharmaceutical compositions
GB2519072B (en)	2019-12-04	Composition comprising collagen and honey
PL3082837T3 (pl)	2021-02-08	Kompozycje zawierające hydrolizat lizozymu do zastosowania w tkance zawierającej keratynę
GB201304699D0 (en)	2013-05-01	Pharmaceutical compositions
EP3003323A4 (en)	2016-12-28	POLYSACCARIDE COMPOSITIONS AND CORRESPONDING METHODS
GB201321497D0 (en)	2014-01-22	Pharmaceutical compositions
GB201312851D0 (en)	2013-09-04	Pharmaceutical compositions